Cost‐effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy‐resistant depression at secondary mental health care settings

AIM: Pharmacotherapy is the primary treatment strategy in major depression. However, two‐thirds of patients remain depressed after the initial antidepressant treatment. Augmented cognitive behavioral therapy (CBT) for pharmacotherapy‐resistant depression in primary mental health care settings proved...

Descripción completa

Detalles Bibliográficos
Autores principales: Sado, Mitsuhiro, Koreki, Akihiro, Ninomiya, Akira, Kurata, Chika, Mitsuda, Dai, Sato, Yasunori, Kikuchi, Toshiaki, Fujisawa, Daisuke, Ono, Yutaka, Mimura, Masaru, Nakagawa, Atsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293226/
https://www.ncbi.nlm.nih.gov/pubmed/34459077
http://dx.doi.org/10.1111/pcn.13298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293226/
https://www.ncbi.nlm.nih.gov/pubmed/34459077
http://dx.doi.org/10.1111/pcn.13298

Ejemplares similares